These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33863)

  • 21. Nadolol and propranolol in the treatment of hypertension: a double-blind comparison.
    El Mehairy MM; Shaker A; Ramadan M; Hamza S; Tadros SS
    J Int Med Res; 1980; 8(3):193-8. PubMed ID: 6104614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative study of the anti-angina effectiveness of nadolol and propranolol].
    Cremonesi A; Pagliarani PL; Guelfi P; Mattace R; Costa G; Bernardi G; Zacà F
    Boll Soc Ital Cardiol; 1979; 24(7):741-5. PubMed ID: 45306
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparative study of the effects of penbutolol and propranolol in the treatment of angina pectoris.
    Hillis WS; Tweddel AC; Murray RG; Lawrie TD
    Arzneimittelforschung; 1980; 30(9):1595-9. PubMed ID: 7006619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metoprolol in angina pectoris complicated by essential hypertension. A clinical comparison of the antianginal efficacy of metoprolol slow-release tablets (Durules) given once daily and propranolol tablets given twice daily.
    BLoem TJ; Lindner PC
    Ann Clin Res; 1981; 13 Suppl 30():61-7. PubMed ID: 6794420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of nadolol, a new long-acting beta-receptor blocking agent, and placebo in the treatment of stable angina pectoris.
    Shapiro W; Park J; DiBianco R; Singh SN; Katz RJ; Fletcher R
    Chest; 1981 Oct; 80(4):425-30. PubMed ID: 6791883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of metoprolol, a cardioselective beta-blocking agent, during chronic therapy in patients with angina pectoris.
    Borer JS; Comerford MB; Sowton E
    J Int Med Res; 1976; 4(1):15-22. PubMed ID: 799974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study of two beta-adrenergic blocking drugs in angina pectoris.
    Stroescu V; Theodorini S; Creţescu R
    Rev Roum Med Intern; 1974; 11(3):307-11. PubMed ID: 4152108
    [No Abstract]   [Full Text] [Related]  

  • 28. Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris.
    Jackson G; Atkinson L; Oram S
    Br Med J; 1975 Mar; 1(5960):708-12. PubMed ID: 804952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiorespiratory effects of isosorbide dinitrate and nifedipine in combination with nadolol: a double-blind comparative study of beneficial and adverse antianginal drug interactions.
    Tirlapur VG; Mir MA
    Am J Cardiol; 1984 Feb; 53(4):487-92. PubMed ID: 6141727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Celiprolol in angina pectoris.
    Soberman JE; Frishman WH
    Am Heart J; 1988 Nov; 116(5 Pt 2):1422-5. PubMed ID: 2903653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of tolamolol versus propranolol on systolic time intervals in angina.
    Aronow WS; Vawter M; Spivack N; Warren M; Laverty W
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1069-76. PubMed ID: 4154826
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison of epanolol and nifedipine in stable angina patients: results of a multicentre trial.
    Blake P; Berry SC; Readman A; Ratcliffe M; Godley M
    Cardiology; 1991; 79(4):249-55. PubMed ID: 1685942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Managing angina with beta blockers.
    Segal BL; Kotler MN; Iskandrian AS
    Geriatrics; 1982 Oct; 37(10):69-72, 76. PubMed ID: 6126421
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical evaluation of bisoprolol in patients with stable angina pectoris: a preliminary report.
    Kato K; Niitani H; Kanazawa T; Shimomura K; Toyama S
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S154-9. PubMed ID: 2439788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind trial of penbutolol: a new beta-receptor blocking agent in the treatment of angina pectoris.
    Agarwal AK; Ahuja RC; Chandra M; Gupta NN; Hasan M
    J Int Med Res; 1976; 4(6):410-7. PubMed ID: 17557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative study of the action of a series of new beta-adrenergic receptor blockaders in patients with effort angina].
    Romakov AIu; Sagirov AM; Desiatnichenko VM; Sobol' IuS; Sumarokov AB
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):57-63. PubMed ID: 6139118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of nadolol in angina pectoris.
    Cruz J; Conceicao JM; Coelho EM
    Practitioner; 1982 Aug; 226(1370):1452-3. PubMed ID: 6127670
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparison of carteolol and nadolol in the treatment of stable angina pectoris.
    Luther RR; Glassman HN; Jordan DC
    J Clin Pharmacol; 1988 Jul; 28(7):634-9. PubMed ID: 3063728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of carvedilol and atenolol efficacy in patients with stable effort angina].
    Martsevich SIu; Koniakhina IP; Alimova EV; Kutishenko NP; Lerman OV
    Ter Arkh; 2001; 73(1):38-41. PubMed ID: 11234138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical and cardiohemodynamic effects of the new long-acting beta-blocker tobanum].
    Ol'binskaia LI; Vartanova OA
    Kardiologiia; 1986 Feb; 26(2):48-51. PubMed ID: 2422430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.